Outcomes after deep brain stimulation in patients with Parkinson s disease (PD) with a mutation in the GBA gene are generally comparable to those of patients with PD not carrying this mutation.
Offering levodopa/carbidopa as a 24-hour continuous subcutaneous infusion could help to improve treatment on times and motor experiences of daily living compared with oral preparations.
A four-strain probiotic helped patients with Parkinson s disease and constipation reduce the delay in levodopa treatment effect and improve symptoms such as sleep and fatigue, in a randomized trial.
The federal Office for Human Research Protections has taken the unusual step of suspending all federally supported research at the New York State Psychiatric Institute, which is affiliated with Columbia University.